Fosfomycin: an underrated antibiotic for urinary tract infections due to Escherichia coli (Q43885940)

27 November 2017

Fosfomycin: an underrated antibiotic for urinary tract infections due to Escherichia coli (English)

1 reference

27 November 2017

urinary tract infection

1 reference

1 reference

Garau M

1

1 reference

PubMed ID

11844449

27 November 2017

Latorre A

series ordinal

2

1 reference

PubMed ID

11844449

27 November 2017

Alonso-Sanz M

series ordinal

3

1 reference

27 November 2017

1 December 2001

1 reference

Infectious Diseases and Clinical Microbiology

27 November 2017

1 reference

27 November 2017

19

1 reference

27 November 2017

10

1 reference

27 November 2017

462-466

1 reference

Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Review of published studies on single dose therapy of urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Short-term treatment of urinary tract infections: the french concept

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

The comparative activity of fosfomycin trometamol against organisms isolated from infected urines

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

In vitro susceptibility testing procedures for fosfomycin tromethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Susceptibility of frequent urinary pathogens to fosfomycin trometamol and eight other antibiotics: results of an Italian multicenter survey

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Fosfomycin trometamol (Monuril) versus norfloxacin in single dose for adult female uncomplicated UTIs. Multicenter randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

A comparative double-blind randomised study of single dose fosfomycin trometamol with trimethoprim in the treatment of urinary tract infections in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Fosfomycin trometamol versus amoxycillin--single-dose multicenter study of urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Single-dose fosfomycin trometamol versus multiple-dose cotrimoxazole in the treatment of lower urinary tract infections in general practice. Multicenter Group of General Practitioners

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

General practitioner study: fosfomycin trometamol versus amoxycillin clavulanate in acute urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Fosfomycin trometamol versus netilmicin in children's lower urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Management of urinary tract infections in pregnancy: A review with comments on single dise therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

An open study of the efficacy and safety of single dose fosfomycin trometamol in treatment of hospitalised patients with urinary tract infection (pilot study).

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972702-4

7 January 2021

10.1016/S0213-005X(01)72702-4

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11844449